Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q2 2019 · 10-Q
Revenue$0.00$0.00— vs Q2 2018 Net Income-$17.98K-$17.98KN/M vs Q2 2018 EPS Diluted-$0.01-$0.01— vs Q2 2018 Operating Income-$17,984N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
derived
ended Aug 31, 2018 · filed Oct 10, 2018 · 40 d after period end